<?xml version="1.0" encoding="UTF-8"?>
<p>Trifluridine on the other hand is a synthetic pyrimidine nucleoside that is frequently used for the treatment of herpetic keratitis as a topical formulation. This drug was approved by the FDA in 1980 for its use as a 1% solution treatment for HSV-related keratitis and is at present one of the most common used topical antiviral for this type of affection in the United States (
 <xref rid="B36" ref-type="bibr">Chou and Hong, 2014</xref>), with considerable effectivity reported (
 <xref rid="B200" ref-type="bibr">Wilhelmus, 2015</xref>). However, local side effects have been described, some particularly severe. 
 <xref rid="T1" ref-type="table">Table 1</xref> summarizes the antiviral activity of these compounds.
</p>
